Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.
Psycheceutical has raised $100K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2024.
Psycheceutical's investors include Cantheon Capital.
Psycheceutical is headquartered in Fort Lauderdale, United States.
Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.
Psycheceutical is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Psycheceutical — Funding & Investors." VCBacked, July 2, 2024, https://www.vcbacked.co/company/psycheceutical. Accessed September 30, 2026.
VCBacked. (2024). Psycheceutical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/psycheceutical
{{cite web |title=Psycheceutical — Funding & Investors |url=https://www.vcbacked.co/company/psycheceutical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated